Le Lézard
Classified in: Health, Business
Subject: BUSINESS CONTRACTS

Emblem Selects No Fixed Address as its Agency of Record



TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) ("Emblem" or the "Corporation") is pleased to announce that it has selected No Fixed Address ("NFA") as its agency of record, following a Request for Proposal process that included five agencies. Through the partnership, NFA and Emblem will work together on marketing communication needs and brand initiatives ahead of legalization, with in-market activities set to begin in early Q2.

Further details on the selection were published in Strategy Online:

http://strategyonline.ca/2018/03/19/emblem-picks-no-fixed-address-as-aor/

About Emblem

Emblem Corp. is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals ? cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol "EMC" on the TSX Venture Exchange.

About No Fixed Address

NFA is a full-service creative and digital agency designed to provide clients with the experience of a roster of proven talent and an entrepreneurial underpinning to it all. We approach every client challenge with an open mind allowing us to provide a tailored solution that puts your business first. We have no fixed agenda other than to share our true passion for the business that we're in and to make our clients successful.

We are fortunate to work with a range of clients including Questrade, MLSE, J.P. Wiser's, Disney, Canadian Centre for Child Protection, Sunnybrook Health Sciences Centre, RioCan, and Mattamy Homes.

NFA is proud to be ranked as the #3 Digital Agency in Canada in 2017 by Strategy Magazine.

Forward-looking statements

This news release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the use of proceeds from the Offering and the future results of operations, performance and achievements of the Corporation. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Except as required by law, the Corporation disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements. This news release contains information obtained by the Corporation from third parties and believes such information to be accurate but has not independently verified such information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact:

Ali Mahdavi
Emblem Corp.
(416) 962-3300
alimahdavi@emblemcorp.com


These press releases may also interest you

at 15:00
The "Key Medical Imaging Companies in Asia-Pacific, 2018" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific medical imaging industry is in the growth stage. Both established and new medical imaging manufacturers in the...

at 15:00
Joerns Healthcare has announced that David Johnson has been appointed Chief Executive Officer.  David will succeed Terry Sutter who served as interim CEO and is Chairman of the Board. "David is a seasoned operator who...

at 15:00
Trauma center accreditation status has been granted to one additional hospital in Pennsylvania starting November 1, 2018. Level IV Trauma Center Accreditation:  Fulton County Medical Center, McConnellsburg, PA Effective November 1, 2018, this brings...

at 14:45
The "Global POC Hematology Diagnostics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global POC Hematology Diagnostics Market to grow at a CAGR of 8.94% during the period 2018-2022. Global POC Hematology...

at 14:30
The "Global Healthcare IT Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The analysts forecast the global healthcare IT market to grow at a CAGR of 8.4% during the period 2018-2022. Global Healthcare IT Market...

at 14:23
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. ("Cocrystal" or the "Company") and of Cocrystal's...




News published on 19 march 2018 at 16:03 and distributed by: